Stock screener

VRDN

Conviction 55HealthcareScan · Thu, Sep 24, 2026

Viridian Therapeutics, Inc.\DE (VRDN) closed at $20.67 (-3.55%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 87, -38.8% from its 52-week high, -32.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

VRDN$20.67-3.55%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
Vol MA14 2.06M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Viridian Therapeutics, Inc.\DEPHARMACEUTICAL PREPARATIONSwww.viridiantherapeutics.com ↗
Price20.67
Change-3.55%
Gap-1.59%
Rel volume3.62×
Avg volume1.75M
Avg $ vol38.69M
SMA 2022.37
SMA 5021.80
SMA 20023.20
Price vs 50-5.20%
Price vs 200-10.91%
MA stackbearish
50/200 cross—
Supertrenddown · 23.44
RSI (14)39
MACD hist-0.24
MACD cross—
Stoch %K / %D12 / 19
ADX (14)18
+DI / −DI15 / 24
RSI divergence—
MACD divergence—
ATR %4.41%
ADR %3.88%
52w high33.78
52w low13.30
From 52w high-38.81%
Above 52w low+55.41%
New 52w highNo
SqueezeOff
Bollinger width13.75%
%B-0.05
Donchian pos10.49%
Donchian high24.47
Donchian low20.23
AVWAP (52w high)20.50
vs AVWAP high+0.82%
AVWAP (52w low)19.10
vs AVWAP low+8.20%
OBV trendDown
Chaikin MF (20)-0.09
Today vs 20d3.62×
Avg vol (14d)2.06M
Avg vol (20d)1.75M
Avg $ vol (20d)38.69M
Market cap2.34B
RS Rating87 / 99
RS 3m (vs SPY)+14.37%
RS 6m (vs SPY)-43.91%
RS line new highNo
Trend template2/8
Technical rank20.1
1 week-5.75%
1 month-14.52%
3 months+18.86%
6 months-27.09%
1 year+5.67%
YTD-32.63%
P/E-6.84
P/B3.54
P/S410.40
P/FCF-8.46
EPS-5.31
Div yield—
ROE-51.74%
ROA-31.22%
Debt/Eq0.04
Current16.95
EV/EBITDA-6.46
Gross margin—
Net margin—
Rev growth-12.00%
EPS growth-26.91%
Price target33.70
Target upside63.04%
Analyst ratingBuy
Institutional125.04%
Ent. value2.35B
Revenue2.11M
Net income-127.12M
Gross profit—
Free cash flow-276.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.07M
Employees252
ListedWed, Jun 18, 2014
Free float86.34M
Float %90.5%
Short interest19.51M
Days to cover16.6d
Short volume63.8%
Squeeze score96 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.05 vs −$0.97
Last surprise-8.3% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank20.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance24.83
Support19.79
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in VRDN

All disclosures →
No recent disclosed trades by Congress in VRDN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRDN · open-market 3 buys · 2 sells

InsiderSideShares
Tousignant Jennifer
Chief Legal Officer · Common Stock · 2026-08-19
Sell4.21K
Tousignant Jennifer
Chief Legal Officer · Common Stock · 2026-08-19
Exercise10K
Tousignant Jennifer
Chief Legal Officer · Common Stock · 2026-08-19
Sell10K
Tousignant Jennifer
Chief Legal Officer · Stock Option (Right to Buy) · 2026-08-19
Exercise10K
Tripuraneni Radhika
Chief Medical Officer · Common Stock · 2026-08-14
Exercise40K
Tripuraneni Radhika
Chief Medical Officer · Stock Option (Right to Buy) · 2026-08-14
Exercise40K
Fairmount Funds Management LLC
Director · Common Stock · 2026-05-11
Buy1.18M
Fairmount Healthcare Fund II L.P.
Director · Common Stock · 2026-05-11
Buy1.18M
Fairmount Healthcare Fund II GP LLC
Director · Common Stock · 2026-05-11
Buy1.18M

SEC filings

EDGAR filings in VRDN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.